Pregnancy after embolization therapy for uterine arteriovenous malformation

Objective: To describe childbearing prognosis following embolization therapy for uterine arteriovenous malformation (AVM). Design: Case report and review. Setting: University hospital. Patient(s): Thirteen patients, including our case, who underwent pregnancy after embolization therapy for arteriovenous malformation. Intervention(s): Two successive embolization procedures. Main Outcome Measure(s): Childbearing prognosis following embolization therapy for uterine AVM. Result(s): Bilateral embolization was performed in seven patients. In four cases, including ours, two successive embolization procedures were required to treat the uterine AVM. The longest delay between embolization and pregnancy was 5 years and the shortest was six weeks. Two patients presented with postpartum hemorrhage which was treated medically. One neonate required resuscitation after delivery in the context of Listeria infection. Conclusion(s): Conservative management of uterine AVMs using embolization therapy is being increasingly developed. New embolization agents and hyperselective technical procedures aim at reducing morbidity related to such treatments and preserving reproductive capacity in women of childbearing age.